4DMedical Ltd Trading Halt Pending US Congress Bill Implications
Key points
- Trading halt requested by 4DMedical Ltd
- Halt due to potential implications of a US Congress bill
- Halt to remain until announcement release or Friday, 17 July 2026
- Company expects to release announcement before Friday trading
Full summary
4DMedical Limited (ASX: 4DX) has requested a trading halt on its securities to manage its continuous disclosure obligations. The halt is in anticipation of an announcement related to a proposed bill in the US Congress. The halt will remain in effect until the announcement is released or until the start of normal trading on Friday, 17 July 2026. The company expects to release the announcement before Friday's trading begins.
Outlook
Pending the release of the announcement regarding the US Congress bill's implications.
Summary generated by a large language model. Please interpret with care.